A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 64,256 shares of BMY stock, worth $3.62 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
64,256
Previous 64,510 0.39%
Holding current value
$3.62 Million
Previous $2.68 Million 24.11%
% of portfolio
0.08%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $10,073 - $13,144
-254 Reduced 0.39%
64,256 $3.33 Million
Q2 2024

Aug 15, 2024

SELL
$40.25 - $52.99 $2,254 - $2,967
-56 Reduced 0.09%
64,510 $2.68 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $7,724 - $8,758
161 Added 0.25%
64,566 $3.5 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $74,416 - $88,799
-1,535 Reduced 2.33%
64,405 $3.3 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $18,987 - $21,231
-328 Reduced 0.49%
65,940 $3.83 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $36,059 - $40,038
-566 Reduced 0.85%
66,268 $4.24 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $12,813 - $14,533
195 Added 0.29%
66,834 $4.63 Million
Q4 2022

Feb 21, 2023

SELL
$68.48 - $81.09 $867,504 - $1.03 Million
-12,668 Reduced 15.97%
66,639 $4.79 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $1,938 - $1.15 Million
-14,910 Reduced 15.83%
79,307 $5.64 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $161,652 - $178,035
-2,226 Reduced 2.31%
94,217 $7.26 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $830,225 - $995,514
-13,504 Reduced 12.28%
96,443 $7.04 Million
Q4 2021

Feb 03, 2022

SELL
$53.63 - $62.52 $79,104 - $92,217
-1,475 Reduced 1.32%
109,947 $6.86 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $590,161 - $691,297
9,974 Added 9.83%
111,422 $6.59 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $7,491 - $8,157
-121 Reduced 0.12%
101,448 $6.78 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $1.33 Million - $1.5 Million
-22,441 Reduced 18.1%
101,569 $6.41 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $16,744 - $18,974
-290 Reduced 0.23%
124,010 $7.69 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $8.18 Million - $9.56 Million
-149,223 Reduced 54.56%
124,300 $7.31 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $8.47 Million - $12.3 Million
182,463 Added 200.38%
273,523 $15.2 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $1.42 Million - $1.85 Million
28,767 Added 46.18%
91,060 $5.85 Million
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $10,649 - $12,626
249 Added 0.4%
62,293 $3.16 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $8.3 Million - $9.18 Million
-186,050 Reduced 74.99%
62,044 $2.81 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $95,925 - $114,378
2,126 Added 0.86%
248,094 $11.8 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $1.93 Million - $2.5 Million
-39,595 Reduced 13.87%
245,968 $12.8 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $1.51 Million - $1.71 Million
-27,443 Reduced 8.77%
285,563 $17.7 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $800,395 - $997,603
15,840 Added 5.33%
313,006 $17.3 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $4.35 Million - $5 Million
-72,524 Reduced 19.62%
297,166 $18.8 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $120,958 - $131,876
2,018 Added 0.55%
369,690 $22.7 Million
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $572,735 - $660,983
-10,370 Reduced 2.74%
367,672 $23.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
314,331 Added 493.37%
378,042 $21.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
63,711
63,711 $4.69 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.